Prostate Cancer - Results from #25760

Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI - Abstract May 25, 2012

Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer - Abstract May 25, 2012

Detecting prostate cancer with MRI - why and how - Abstract May 25, 2012

Endocrine prevention and treatment of prostate cancer - Abstract May 25, 2012

Imaging techniques for local recurrence of prostate cancer: For whom, why and how? - Abstract May 25, 2012

Phase I/II trial of single-fraction high-dose-rate brachytherapy-boosted hypofractionated intensity-modulated radiation therapy for localized adenocarcinoma of the prostate - Abstract May 25, 2012

AUA 2012 - The association between male pattern baldness and second to fourth finger ratio with prostate cancer - a prospective cohort study - Press Briefing May 24, 2012

Validation in Spain of the Quality of Life Questionnaire PROSQOLI in patients with advanced prostate cancer - Abstract May 24, 2012

Healthcare resource use in advanced prostate cancer patients treated with docetaxel - Abstract May 24, 2012

Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: Report from a Consensus Panel - Abstract May 24, 2012

Beyond PSA: The next generation of prostate cancer biomarkers - Abstract May 24, 2012

AUA 2012 - Genetic variants associated with severity of lower urinary tract symptoms and prostate cancer susceptibility - Press Release May 24, 2012

AUA 2012 - The association between male pattern baldness and second to fourth finger ratio with prostate cancer - a prospective cohort study - Video Lecture May 23, 2012

AUA 2012 - A closer look at PSA testing and prostate cancer: The screening debate, genetic connection and risk in young men - Press Release May 23, 2012

AUA 2012 - Perspectives from the AUA - PSA controversy: Do the harms exceed the benefits or the benefits exceed the harms? - Video statement from William J. Catalona, MD May 23, 2012

No evidence for infection of UK prostate cancer patients with XMRV, BK virus, Trichomonas vaginalis or human papilloma viruses - Abstract May 23, 2012

Using graded response model for the prediction of prostate cancer risk - Abstract May 23, 2012

Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer - Abstract May 23, 2012

Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable results - Abstract May 23, 2012

Transdermal estradiol in castrate and chemotherapy resistant prostate cancer - Abstract May 23, 2012

Page 1289 of 1435